SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-094571
Filing Date
2023-12-11
Accepted
2023-12-11 09:00:28
Documents
83
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_elevailabs.htm   iXBRL 10-Q 1034611
2 CERTIFICATION f10q0923ex31-1_elevailabs.htm EX-31.1 10314
3 CERTIFICATION f10q0923ex31-2_elevailabs.htm EX-31.2 10622
4 CERTIFICATION f10q0923ex32-1_elevailabs.htm EX-32.1 4725
  Complete submission text file 0001213900-23-094571.txt   6161225

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE elab-20230930.xsd EX-101.SCH 75970
6 XBRL CALCULATION FILE elab-20230930_cal.xml EX-101.CAL 37501
7 XBRL DEFINITION FILE elab-20230930_def.xml EX-101.DEF 325649
8 XBRL LABEL FILE elab-20230930_lab.xml EX-101.LAB 583399
9 XBRL PRESENTATION FILE elab-20230930_pre.xml EX-101.PRE 340735
77 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_elevailabs_htm.xml XML 720534
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
Elevai Labs Inc. (Filer) CIK: 0001840563 (see all company filings)

IRS No.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41875 | Film No.: 231477033
SIC: 2834 Pharmaceutical Preparations